Skip to main content
. 2018 Jan 29;7(5):e1424675. doi: 10.1080/2162402X.2018.1424675

Figure 5.

Figure 5.

PFS according to the relative change in ctDNA concentration between baseline and the first tumor evaluation for each patients. Red bars indicate an increase >9% of ctDNA concentration; blue bars indicate an absence of increase >9% of ctDNA concentration. Blue arrows indicate ongoing treatment at the time of the analysis.